Search

everythinglearnresearchcommunity

for

Search:↓

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Low-dose oral minoxidil can improve hair and eyebrow growth in frontal fibrosing alopecia.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Finasteride is considered to have a low risk to fetuses.

Methotrexate plus prednisolone had the fewest serious side effects.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Fzd2 is important for skin and hair development through various signaling ways.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.